Epigenetics Market Is Expected To Reach USD 890.0 Million by 2020


Posted June 8, 2017 by dheerajshaha67

he epigenetics market is expected to grow at a CAGR of 13.64% from 2015 to 2020 to reach USD 890.0 Million by 2020.

 
The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.

Browse 84 market data Tables and 82 Figures spread through 158 Pages and in-depth TOC on “Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020”

http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global epigenetics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are Biotechnology and Biological Sciences Research Council, European Federation of Biotechnology and International Human Epigenome Consortium.

Industry Insights:
In this report, the global market of Epigenetics is segmented based on product, research areas and geography. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=896

Geographical Scenario:

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada. In 2015, the North America is expected to command the largest share of the global epigenetics market. Asia is expected to register the highest growth due to high prevalence of cancer, increasing research activities by various research institutes and increasing R & D funding by biotechnology and pharmaceutical companies in this region.

Request a sample of the report:
http://www.marketsandmarkets.com/requestsample.asp?id=896

Industry Leaders:

Major players in the global epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: [email protected]
Tel: 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By D Shaha
Country India
Categories Biotech , Business
Tags epigenetics marke , global epigenetics market
Last Updated June 8, 2017